Literature DB >> 3145062

Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction.

J M Cruickshank1.   

Abstract

The results of several large studies of hypertension and follow up studies on insured people have indicated that the lower the blood pressure the better for longevity. These studies excluded subjects with overt ischaemia. More recently long term studies of hypertension that included patients with more severe forms of hypertension and did not exclude those with overt ischaemia have shown a J shaped relation between diastolic blood pressure during treatment and myocardial infarction; the lowest point (the J point) was at a diastolic blood pressure (phase V) between 85 and 90 mm Hg. The J curve seems to be independent of treatment, pulse pressure, and the degree of fall in diastolic blood pressure and is unlikely to be caused by poor left ventricular function. The most probable explanation is that subjects who have severe stenosis of the coronary artery as well as hypertension have a poor coronary flow reserve, which makes the myocardium vulnerable to coronary perfusion pressures that are tolerated by patients without ischaemia, particularly at high heart rates. An optimal diastolic blood pressure (phase V) for such patients is about 85 mm Hg, though particular caution is appropriate when treating very old patients (84 and over) and patients aged 60-79 who have isolated systolic hypertension.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145062      PMCID: PMC1834729          DOI: 10.1136/bmj.297.6658.1227

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  18 in total

1.  Randomised trial of treatment of hypertension in elderly patients in primary care.

Authors:  J Coope; T S Warrender
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

2.  Long-term observations on high blood-pressure presenting in fit young men.

Authors:  I M Stewart
Journal:  Lancet       Date:  1971-02-20       Impact factor: 79.321

Review 3.  Role of blood pressure in cardiovascular morbidity and mortality.

Authors:  W B Kannel
Journal:  Prog Cardiovasc Dis       Date:  1974 Jul-Aug       Impact factor: 8.194

4.  Heart attacks and lowering of blood pressure.

Authors:  J M Cruickshank; J M Thorp; F J Zacharias
Journal:  Lancet       Date:  1987-05-16       Impact factor: 79.321

5.  Lowering blood pressure.

Authors:  J Coope; T S Warrender
Journal:  Lancet       Date:  1987-08-29       Impact factor: 79.321

6.  Re-examination of some of the Framingham blood-pressure data.

Authors:  T W Anderson
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

7.  Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Göteborg, Sweden.

Authors:  O Samuelsson; L Wilhelmsen; O K Andersson; K Pennert; G Berglund
Journal:  JAMA       Date:  1987-10-02       Impact factor: 56.272

8.  Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease?

Authors:  P C Waller; C G Isles; A F Lever; G D Murray; G T McInnes
Journal:  J Hum Hypertens       Date:  1988-06       Impact factor: 3.012

9.  Benefits and potential harm of lowering high blood pressure.

Authors:  J M Cruickshank; J M Thorp; F J Zacharias
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

10.  Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension.

Authors:  I M Stewart
Journal:  Lancet       Date:  1979-04-21       Impact factor: 79.321

View more
  49 in total

Review 1.  Systolic versus diastolic blood pressure versus pulse pressure.

Authors:  William B White
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

2.  INVESTing in hypertension.

Authors:  Robert M Carey
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

Review 3.  Evidence for aggressive blood pressure-lowering goals in patients with coronary artery disease.

Authors:  Monisankar Roy; Noman Mahmood; Clive Rosendorff
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

Review 4.  Hypertension.

Authors:  G W Ching; D G Beevers
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

Review 5.  Management of mild hypertension. Selecting an antihypertensive regimen.

Authors:  E J Pérez-Stable
Journal:  West J Med       Date:  1991-01

Review 6.  Clinical trials and clinical practice in the elderly. A focus on hypertension.

Authors:  M E Kitler
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

Review 7.  Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Authors:  D G Waller
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

8.  Low blood pressure and five-year mortality in a Stockholm cohort of the very old: possible confounding by cognitive impairment and other factors.

Authors:  Z Guo; M Viitanen; B Winblad
Journal:  Am J Public Health       Date:  1997-04       Impact factor: 9.308

9.  Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.

Authors:  P Sever; G Beevers; C Bulpitt; A Lever; L Ramsay; J Reid; J Swales
Journal:  BMJ       Date:  1993-04-10

Review 10.  Oscillating blood pressure therapeutic target in type 2 diabetes patients with hypertension.

Authors:  Aurel T Tankeu; Jean Jacques N Noubiap
Journal:  Ann Transl Med       Date:  2016-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.